EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nebulization of 2% lidocaine has no detectable impact on the healthy equine respiratory microbiota

Lauren Holley, Hannah N Creasey, Daniela Bedenice iD, Sarah Reed, Debora Regina Romualdo da Silva iD, Victoria Trautwein, Melissa Mazan, Giovanni Widmer

PLOS ONE · 2025

DOI: 10.1371/journal.pone.0316079 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Lauren Holley und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cummings School of Veterinary Medicine at Tufts University, Department of Clinical Sciences, North Grafton, MA, United States of America. Hauptthemen laut MEDLINE: Lidocaine, Microbiota. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIDDK NIH HHS, Dorothy Russell Havemeyer Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucocorticosteroids remain the most common pharmaceutical approach for the treatment of equine asthma but can be associated with significant side effects, including respiratory microbiome alterations. The goal of the study was to assess the impact of 2% lidocaine nebulization, a projected alternative treatment of equine asthma, on the healthy equine respiratory microbiota. A prospective, randomized, controlled, blinded, 2-way crossover study was performed, to assess the effect of 1 mg/kg 2% lidocaine (7 treatments over 4 days) on the equine respiratory microbiota compared to control horses (saline and no treatment). Clinical assessments and respiratory samples, including nasal wash, endoscopic tracheal aspirate and bronchoalveolar lavage fluid, were obtained at each sample collection timepoint. The profile of the respiratory bacterial microbiota was evaluated using 16S amplicon sequencing, and clinical data compared using related samples analyses, based on data normality. The treatment did not affect the clinical data or alter the tracheal and nasal microbiota in healthy horses. However, time explained 12.6% of microbiota variation among samples. A significant difference in bacterial composition was observed between nasal and tracheal samples, showing the greatest relative abundance of Actinobacteria and Firmicutes, respectively. Bacterial DNA from bronchoalveolar lavage fluid did not amplify with generic primers targeting the V4 variable region of the prokaryotic small subunit ribosomal RNA gene, despite attempting multiple DNA extraction methods and PCR protocols, and after excluding PCR inhibition. This observation indicates that bronchoalveolar lavage fluid of healthy horses has a low bacterial load.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LidocaineMicrobiotaAnimalsBacteriaBronchoalveolar Lavage FluidCross-Over StudiesHorsesNebulizers and VaporizersProspective StudiesRNA, Ribosomal, 16STrachea

Substanzen

LidocaineRNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Cummings School of Veterinary Medicine at Tufts University, Department of Clinical Sciences, North Grafton, MA, United States of America.
  • Cummings School of Veterinary Medicine at Tufts University, Department of Infectious Diseases and Global Health, North Grafton, MA, United States of America.
  • University of Connecticut, Department of Animal Science, Storrs, CT, United States of America.
  • São Paulo State University (UNESP), School of Veterinary Medicine, Araçatuba, São Paulo, Brazil.

ORCID-Profile: Daniela Bedenice, Debora Regina Romualdo da Silva

Förderung

  • NIAID NIH HHS
  • NIDDK NIH HHS
  • Dorothy Russell Havemeyer Foundation
  • Companion Animal Health Fund
  • Grayson-Jockey Club Research Foundation
  • Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Holley, L., Creasey, H. N., Bedenice, D., Reed, S., Romualdo da Silva, D. R., Trautwein, V., Mazan, M., & Widmer, G. (2025). Nebulization of 2% lidocaine has no detectable impact on the healthy equine respiratory microbiota. PLOS ONE. https://doi.org/10.1371/journal.pone.0316079

Vancouver

Holley L, Creasey HN, Bedenice D, Reed S, Romualdo da Silva DR, Trautwein V, et al. Nebulization of 2% lidocaine has no detectable impact on the healthy equine respiratory microbiota. PLOS ONE. 2025. doi:10.1371/journal.pone.0316079

BibTeX
@article{Holley2025,
  author = {Holley, Lauren and Creasey, Hannah N and Bedenice, Daniela and Reed, Sarah and Romualdo da Silva, Debora Regina and Trautwein, Victoria and Mazan, Melissa and Widmer, Giovanni},
  title = {Nebulization of 2% lidocaine has no detectable impact on the healthy equine respiratory microbiota},
  journal = {PLOS ONE},
  year = {2025},
  doi = {10.1371/journal.pone.0316079}
}
Kostenlos starten →